MRK vs PGNY · P/E 33, rev $16.61B vs P/E 38, rev $679.0M
Merck & Company Inc (MRK) versus Progyny Inc (PGNY) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Progyny Inc (PGNY) is a healthcare plans company listed on US.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported PGNY revenue for 2026-06-30 was $679.0M. Net income was $52.3M. PGNY currently screens at market cap $1.84B and trailing P/E 37.6.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. PGNY currently screens at market cap $1.84B and trailing P/E 37.6.
Not investment advice. Open the MRK and PGNY stock pages for the full models.
Not investment advice.